An Official Website of the United States Government
Company Information:
Name:
BIOPOWERTECH
Address:
BIOPOWERTECH
4734 BLUEGRASS PKY
TUSCALOOSA, AL 35406 4040
4734 BLUEGRASS PKY
TUSCALOOSA, AL 35406 4040
Located in HUBZone:
No
Woman-Owned:
Yes
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Decoy receptor 3 and liver cirrhosis
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Sunghee Kim
Award Amount:
$109,681.00
Abstract:
DESCRIPTION (provided by applicant): Liver cirrhosis is a chronic and degenerative disease that can lead to inability of the liver to perform its biochemical function thus severely affecting the quality of patients' life. Currently, liver biopsy is the gold standard in determining the presence of… More
A therapeutic potential of soluble decoy receptor 3 in sepsis
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Sunghee Kim
Award Amount:
$112,572.00
Abstract:
DESCRIPTION (provided by applicant): Sepsis a serious life-threatening condition resulting from a harmful inflammatory reaction of the body due to bacterial infection. The mortality rate of sepsis remains high in intensive care units around the world but therapeutic interventions have been largely… More
Soluble Decoy Receptor 3 in Bacterial Infection and Sepsis
Award Year / Program / Phase:
2006 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Sunghee Kim
Award Amount:
$107,000.00
Abstract:
DESCRIPTION (provided by applicant): Sepsis is a serious inflammatory reaction of the body due to bacterial infection, and the mortality rate of severe sepsis is high in intensive care units around the world. There is a great need for inventing a reliable marker to diagnose patients with sepsis in… More
Development of immunoassay to measure a novel TNF-like protein
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Sunghee Kim
Award Amount:
$115,389.00
Abstract:
DESCRIPTION (provided by applicant): The tumor necrosis factor (TNF) family cytokines (ligands) mediate diverse immune responses via the activation of their cognate receptors expressed on the cell surface. Dysregulation and genetic defects of these cytokin
es are known to be involved in various… More
A novel therapy for sepsis
Award Year / Program / Phase:
2007 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Sunghee Kim
Award Amount:
$203,439.00
Abstract:
Description: (Provided by Applicant) Sepsis a serious life-threatening condition resulting from a harmful inflammatory reaction of the body due to bacterial infection. The mortality rate of sepsis remains high in intensive care units around the world but t
herapeutic interventions have been largely… More
Targeting Deceoy Receptor 3 in Breast Cancer
Award Year / Program / Phase:
2008 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Sunghee Kim
Award Amount:
$335,322.00
Abstract:
DESCRIPTION (provided by applicant): Breast cancer is the leading cause of cancer deaths in the United States. In this year alone, approximately 40,480 women in the US are estimated to die from breast cancer. In most cases, death results from metastasis of
breast cancer cells. Cancer patients with… More
Development of recombinant rhTL1A protein for cancer treatment
Award Year / Program / Phase:
2010 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Sunghee Kim
Award Amount:
$329,560.00
Abstract:
DESCRIPTION (provided by applicant): Breast cancer is the most common cause of cancer in women and the second most common cause of cancer death in women in the United States. In 2009, approximately 40,170 women in the US are estimated to die from breast ca
ncer. In most cases, death results from… More